Novo Nordisk: Will Wegovy And Pipeline Spark Rally?

Novo Nordisk is quietly coming out of the storm despite the prevailing pessimism, especially among retail investors. Click ...

Obesity Drug Access Grows as Novo, Lilly Sell Direct to Employers

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...
HealthDay on MSN

Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy

HealthDay News — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that ...

GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis

Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

Obesity-drugmaker Novo Nordisk helps drive Denmark's fastest growth in years

Denmark's GDP grew by the most in four years as Novo Nordisk continues to boost the small Nordic country's economy.
BioSpace

Eli Lilly Enters Uncharted Territory as Market Cap Nears $1T

Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...
KETK.com

Novo cuts Wegovy prices, but doctors still see cost challenges for patients

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...